Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells

British Journal of Pharmacology

Volumn 159, Issue 8, 2010, Pages 1693-1703

  Pang, Wai Yin ^a,b   Wang, Xin Lun ^c   Mok, Sau Keng ^a,b   Lai, Wan Ping ^a,b   Chow, Hung Kay ^a   Leung, Ping Chung ^d   Yao, Xin Sheng ^c,e   Wong, Man Sau ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e JINAN UNIVERSITY   (China)

Author keywords

BMD; Naringin; Oestrogen receptors; Osteoprotegerin; RANKL

Indexed keywords

AURANTIIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE; BONE DENSITY; C57BL 6 MOUSE; CANCER CELL CULTURE; CELL ENERGY; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN UMR 106; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAPHYSIS; DRUG ACTIVITY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; FEMALE; FEMUR; HORMONE ACTION; LUMBAR SPINE; MOUSE; MUSCULOSKELETAL FUNCTION; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; STRESS STRAIN RELATIONSHIP; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; BONE DENSITY; CELL LINE; DNA PRIMERS; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; FLAVANONES; MICE; MICE, INBRED C57BL; ORGAN SIZE; OSTEOBLASTS; OVARIECTOMY; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED; UTERUS;

EID: 77950204604     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00664.x     Document Type: Article

References (41)

1. Alexander SPH, Mathie A, Peters JA (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
2. Benavente-Garcia O, Castillo J (2008). Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56 : 6185 6205.
3. Bjornstrom L, Sjoberg M (2005). Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19 : 833 842.
4. Bord S, Ireland DC, Beavan SR, Compston JE (2003). The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32 : 136 141.
5. Bunone G, Briand PA, Miksicek RJ, Picard D (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15 : 2174 2183.
6. Chen WF, Wong MS (2006). Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. Br J Nutr 95 : 1039 1047.
7. Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V et al. (2002). Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21 : 4921 4931.
8. Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K et al. (2003). Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133 : 1892 1897.
9. Deng HW, Liu YZ (2005). Current Topics in Bone Biology. World Scientific : Singapore.
10. Deyhim F, Garica K, Lopez E, Gonzalez J, Ino S, Garcia M et al. (2006). Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 22 : 559 563.
11. Deyhim F, Mandadi K, Bahram F, Bhimanagoudo SP (2008a). Grapefruit juice modulates bone quality in rats. J Med Food 11 : 99 104.
12. Deyhim R, Mandadi K, Patil BS, Faraji B (2008b). Grapefruit pulp increase antioxidant status and improves bone quality in orchidecotmized rats. Nutrition 4 : 1039 1044.
13. Dixon RA (2004). Phytoestrogens. Annu Rev Plant Biol 55 : 225 261.
14. Erlund I, Meririnne E, Alfthan G, Aro A (2001). Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131 : 235 241.
15. Gass M, Dawson-Hughes B (2006). Preventing osteoporosis-related fractures: an overview. Am J Med 119 : S3 S11.
16. Gasser JA (2002). Bone measurements by peripheral quantitative computed tomography in rodents. Methods Mol Med 80 : 323 341.
17. Gutendorf B, Westendorf J (2001). Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166 : 79 89.
18. Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H (2003). Markers of bone resorption - measurement in serum, plasma or urine? Clin Lab 49 : 203 207.
19. Ishii K, Furuta T, Kasuya Y (2000). Mass spectrometric identification and high-performance liquid chromatographic determination of a flavonoids glycoside naringin in human urine. J Agric Food Chem 48 : 56 59.
20. Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I (2007). Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 61 : 472 477.
21. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 : 1491 1494.
22. Kim SY, Kim HJ, Lee MK, Jeon SM, Do GM, Kwon EY et al. (2006). Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet. J Med Food 9 : 582 586.
23. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA et al. (2002). Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298 : 843 846.
24. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC (2007). Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 27 : 1516 1530.
25. Kuiper G, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with ERβ. Endocrinology 139 : 4252 4263.
26. Lannigan DA (2003). Estrogen receptor phosphorylation. Steroids 68 : 1 9.
27. Lau EM, Cooper C (1996). The epidemiology of osteoporosis. The oriental perspective in a world context. Clin Orthop Relat Res 323 : 65 74.
28. Lau WS, Chan RYK, Guo DA, Wong MS (2008). Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERα pathway. J Steroid Biochem Mol Biol 108 : 64 71.
29. Lees JA, Fawell SE, Parker MG (1989). Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 17 : 5477 5488.
30. Lu Y, Zhang C, Bucheli P, Wei D (2006). Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China. Plant Foods Hum Nutr 61 : 57 65.
31. Mandadi K, Ramirez M, Jayaprakasha GK, Faraji B, Lihono M, Deyhim F et al. (2008). Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine 16 (6-7 513 520.
32. Obsborne CK, Wakeling A, Nicholson RI (2004). Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90 (Suppl. 1 S2 S6.
33. So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK (1996). Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 26 : 167 181.
34. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E et al. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59 : 477 487.
35. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB et al. (1994). Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8 : 21 30.
36. Wei M, Yang Z, Li P, Zhang Y, Sse WC (2007). Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35 : 663 667.
37. Wong RW, Rabie AB (2006). Effect of naringin on bone cells. J Orthop Res 24 : 2045 2050.
38. Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH (2008). Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588 : 333 341.
39. Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY, Yao XS et al. (2005). The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Altern Med 2 : 353 361.
40. Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008). Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus Ligustri Lucidi. Br J Nutr 99 : 494 502.
41. Zhang Y, Dong XL, Lai WP, Helferich W, Wong MS (2009). Differential effects of genistein and a soy extract on three-dimensional bone parameters and the expression of bone specific genes in ovariectomized mice. J Nutr 139 : 2230 2236.